BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8262826)

  • 21. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.
    Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Antoine JM; Jannet D; Lhuillier P; Uzan M; Huart J; Genestie C; Antoine M; Jamali M; Ganansia V; Milliez J; Uzan S; Blondon J
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):780-93. PubMed ID: 12377330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prediction of late rectal complications following the treatment of uterine cervical cancer by high-dose-rate brachytherapy.
    Chen SW; Liang JA; Yang SN; Liu RT; Lin FJ
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):955-61. PubMed ID: 10863065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical evaluation of the effectiveness of radiation treatment for cervical cancer].
    Turkevich VG
    Vopr Onkol; 2014; 60(3):366-70. PubMed ID: 25033692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uterosacral space involvement in locally advanced carcinoma of the uterine cervix.
    Chao KS; Williamson JF; Grigsby PW; Perez CA
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):397-403. PubMed ID: 9457827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: patterns of care study.
    Eifel PJ; Moughan J; Owen J; Katz A; Mahon I; Hanks GE
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):351-8. PubMed ID: 10030261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective randomized study concerning the point A dose in high-dose rate intracavitary therapy for carcinoma of the uterine cervix. The final results.
    Chatani M; Matayoshi Y; Masaki N; Teshima T; Inoue T
    Strahlenther Onkol; 1994 Nov; 170(11):636-42. PubMed ID: 7974179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency.
    Vasanthan A; Mitsumori M; Park JH; Zhi-Fan Z; Yu-Bin Z; Oliynychenko P; Tatsuzaki H; Tanaka Y; Hiraoka M
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):145-53. PubMed ID: 15629605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined external and intracavitary irradiation in treatment of advanced cervical carcinomas: predictive factors for treatment outcome and early and late radiation reactions.
    Bohr Mordhorst L; Karlsson L; Bärmark B; Sorbe B
    Int J Gynecol Cancer; 2014 Sep; 24(7):1268-75. PubMed ID: 25078336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix.
    Kim WC; Kim GE; Suh CO; Loh JJ
    Jpn J Clin Oncol; 2001 Sep; 31(9):432-7. PubMed ID: 11689597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Curietherapy-surgery for epidermoid carcinomas of the uterine cervix T1].
    Thomas L; Pigneux J; Cowen D; Carricaburu M; Avril A; Bussières E; Stöckle E; Marée D
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(7):947-54. PubMed ID: 1791287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
    Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
    J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix.
    Fields AL; Anderson PS; Goldberg GL; Wadler S; Beitler J; Sood B; Runowicz CD
    Gynecol Oncol; 1996 Jun; 61(3):416-22. PubMed ID: 8641625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
    Lerouge D; Touboul E; Lefranc JP; Uzan S; Jannet D; Moureau-Zabotto L; Genestie C; Antoine M; Jamali M
    Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of balloon occluded arterial infusion of anticancer drugs on the prognosis of cervical cancer treated with radiation therapy.
    Tsuji K; Yamada R; Kawabata M; Mitsuzane K; Sato M; Iwahashi M; Kitayama S; Nakano R
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1337-45. PubMed ID: 7635773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Preoperative endocavitary curietherapy of stage Ib-IIa-IIb cervical carcinoma. Personal observations].
    Gabriele AM; Boidi Trotti A; Fracchia F; Rosmino C; Rovea P; Tardy A
    Radiol Med; 1989 May; 77(5):521-3. PubMed ID: 2748964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transition from LDR to HDR brachytherapy for cervical cancer: Evaluation of tumor control, survival, and toxicity.
    Romano KD; Pugh KJ; Trifiletti DM; Libby B; Showalter TN
    Brachytherapy; 2017; 16(2):378-386. PubMed ID: 28139420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term results of low-dose-rate interstitial-intracavitary brachytherapy in the treatment of carcinoma of the cervix.
    Syed AM; Puthawala AA; Abdelaziz NN; el-Naggar M; Disaia P; Berman M; Tewari KS; Sharma A; Londrc A; Juwadi S; Cherlow JM; Damore S; Chen YJ
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):67-78. PubMed ID: 12182976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radical radiation therapy for adenocarcinoma of the uterine cervix.
    Toita T; Takizawa Y; Nakano M; Sueyama H; Kushi A; Kakihana Y; Ogawa K; Hara R; Higashi M; Sakumoto K
    Strahlenther Onkol; 1994 May; 170(5):277-80. PubMed ID: 8197550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy.
    Mazeron R; Castelnau-Marchand P; Dumas I; del Campo ER; Kom LK; Martinetti F; Farha G; Tailleur A; Morice P; Chargari C; Lefkopoulos D; Haie-Meder C
    Radiother Oncol; 2015 Feb; 114(2):257-63. PubMed ID: 25497872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment outcome of medium-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix: comparison with low-dose-rate intracavitary brachytherapy.
    Kaneyasu Y; Kita M; Okawa T; Maebayashi K; Kohno M; Sonoda T; Hirabayashi H; Nagata Y; Mitsuhashi N
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):137-45. PubMed ID: 22285665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.